Johnson & Johnson announced the launch of the new Johnson & Johnson Center for Global Health Discovery at the Duke-NUS Medical School in Singapore. The centre is jointly established by the National University of Singapore (NUS) and Duke University.
As being the first of the Johnson & Johnson Center for Global Health Discovery or J&J Centers in the region of Asia-Pacific, the Satellite Center at Singapore is aiming for providing help in driving the new solutions for the purpose of addressing the flaviviruses, which are impacting the communities across the Asia-Pacific region by bringing together the expertise Johnson & Johnson.
This launch of the Satellite Center comes at a critical time. Over 400 million people have been infected with the flaviviruses each year and around 50% of the global population is at risk, with the continent of Asia experiencing around three quarters of the global burden.
Ruxandra Draghia-Akli, Global Head, Global Public Health R&D at Janssen Research & Development, LLC, said Singapore has been one of the epicentres of the dengue threat and also a leading innovation and research hub, which has made Duke-NUS a natural match for the vision of the company to address the flaviviruses by advancing innovative science.
He also said that together, each of them can leverage their unique strengths for the purpose of translating the action in the lab into solutions that can possibly help in protecting people against one of the most significant and growing health threats in the world.
Ram is a leading news contributor for IndustryWatch24 and specialises in writing about technology. His enthusiasm for the most recent technological advancements, such as Bitcoin and AI technology, among others, is evident in the most recent industry coverage he offers. He currently presents his analysis of popular business and technological fields, which gives his writing a present and unique perspective.
